Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Certain Diabetes Drugs Like Januvia Associated With Bile Duct Cancer

December 21, 2018 By Law Offices of Thomas J. Lamb, P.A.

The risk of developing bile duct cancer, also known as cholangiocarcinoma, is almost doubled for type 2 diabetics using one of the following diabetes medicines:

Januvia (sitagliptin)
Janumet (sitagliptin / metformin HCl)
Onglyza (saxagliptin)
Kombiglyze XR (saxagliptin and metformin)
Qtern (dapagliflozin and saxagliptin)
Nesina (alogliptin)
Kazano (alogliptin and metformin)
Oseni (alogliptin and pioglitazone)
Tradjenta (linagliptin)
Jentadueto (linagliptin and metformin HCl)
Glyxambi (empagliflozin / linagliptin)

These diabetes medicines are in the dipeptidyl peptidase-4 (DPP-4) inhibitor drug class.

In more detail, a BMJ article, “Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study”, published in December 2018, reports on a medical study whihch showed that the use of DPP-4 inhibitors diabetes drugs was associated with a near doubling of the risk of bile duct cancer.

This December 2018 BMJ medical journal article concluded with an important call-to-action:

Given the high fatality rate of this cancer, post hoc analyses of randomised controlled trials and additional observational studies are needed to corroborate our findings.

We will continue to monitor the medical literature for more about bile duct cancer being a possible side effect of DPP-4 inhibitor diabetes drugs.

[View article at original source]

Free Case Evaluation

Strictly Confidential, No Obligation

 

Filed Under: Unsafe Drugs Tagged With: bile duct cancer, cholangiocarcinoma, diabetes drugs, dpp-4 drugs, Glyxambi, Janumet, Januvia, Jentadueto, Kazano, Kombiglyze XR, Nesina, Onglyza, Oseni, Qtern, Tradjenta

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.